DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Crinone (Progesterone Vaginal) - Indications and Dosage

 
 



INDICATIONS AND USAGE

Assisted Reproductive Technology

Crinone® 8% is indicated for progesterone supplementation or replacement as part of an Assisted Reproductive Technology ("ART") treatment for infertile women with progesterone deficiency.

Secondary Amenorrhea

Crinone® 4% is indicated for the treatment of secondary amenorrhea. Crinone® 8% is indicated for use in women who have failed to respond to treatment with Crinone® 4%.

DOSAGE AND ADMINISTRATION

Assisted Reproductive Technology

Crinone® 8% is administered vaginally at a dose of 90 mg once daily in women who require progesterone supplementation. Crinone® 8% is administered vaginally at a dose of 90 mg twice daily in women with partial or complete ovarian failure who require progesterone replacement. If pregnancy occurs, treatment may be continued until placental autonomy is achieved, up to 10-12 weeks.

Secondary Amenorrhea

Crinone® 4% is administered vaginally every other day up to a total of six doses. For women who fail to respond, a trial of Crinone® 8% every other day up to a total of six doses may be instituted.

It is important to note that a dosage increase from the 4% gel can only be accomplished by using the 8% gel. Increasing the volume of gel administered does not increase the amount of progesterone absorbed.

SEE Crinone® PATIENT INFORMATION SHEET - HOW TO USE Crinone®.

Note: The PATIENT INFORMATION SHEET contains special instructions for using the applicator at altitudes above 2500 feet in order to avoid a partial release of Crinone® before vaginal insertion.

HOW SUPPLIED

Crinone® is available in the following strengths:

4% gel (45 mg) in a single use, one piece, disposable, white polyethylene vaginal applicator with a twist-off top. Each applicator contains 1.45 g of gel and delivers 1.125 g of gel.

NDC-55056-0808-6 - 6 Single-use prefilled applicators.

8% gel (90 mg) in a single use, one piece, disposable, white polyethylene vaginal applicator with a twist-off top. Each applicator contains 1.45 g of gel and delivers 1.125 g of gel.

NDC-55056-0806-2 - 6 Single-use prefilled applicators
NDC-55056-0818-5 - 15 Single-use prefilled applicators
NDC-55056-0818-2 - 18 Single-use prefilled applicators

Each applicator is wrapped and sealed in a foil overwrap.

Store at 25°C (77°F); excursions permitted to 15-30°C (59-86°F).

Rx only.

U.S. Patent Number 5,543,150.

Manufactured for: Columbia Laboratories, Inc. Livingston, NJ 07039

Manufactured by: Fleet Laboratories Ltd., Watford, United Kingdom

Revised May 2009

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017